It’s the start of another exciting year of Lab Expectation articles. What can you expect from us in 2021?
As usual, we’ll mix a bit of the familiar with something completely unexpected. Example: in 2020 we set out to bring you a lot of immunology and cell biology stories. Mission accomplished! However, when I was writing our 2020 preview, I had no idea how much SARS-CoV-2 content the world would be hungry for. At the time, I’m not sure I was even fully aware the virus existed. Such is life though; we can make all the plans we want, and the world will always surprise you.
2021 will be another big year for research area content. There’s so much to explore in the world of neuroscience and neurodegenerative disease. We’ll dig deeper to explore topics like amyloid beta, tau, cell type markers, neuroinflammation, neurotransmission, and assays for neuro degeneration. So many people worldwide suffer from diseases like Alzheimer’s and Parkinson’s. The community has made big strides to improve outcomes for these patients. However, there’s still so much signaling to explore to fully understand the mechanisms at play.
In discussing cell biology last year, we touched on metabolism. But this is such a big topic, it deserves its own series. Metabolism is linked to so many other processes. We’ll look how metabolism is linked to cancer and other diseases, how metabolism is related to hypoxia and glycolysis, and what methods researchers can utilize to measure metabolism.
At the risk of sounding like a game show host…That’s not all!
We’ll be talking about industry awards, the latest scientific discoveries, continuing COVID coverage, exciting opportunities to serve the community and give back, and so much more. In fact, they’ll be too much happening to name here. And if I’ve learned anything as blog editor, I know that even if I tried, the universe is still going to surprise me.
Readers, get ready! Thank you for being a part of the adventure.
Chris Sumner
Editor, Lab Expectations